Title : Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults.

Pub. Date : 2002 Jun 1

PMID : 12015689

1 Functional Relationships(s)
Compound Name
Protein Name
1 For the assessable recipients of cefazolin-probenecid (n=59) and ceftriaxone-placebo (n=57), clinical cure occurred at the end of treatment in 86% and 96% (P=.11), respectively, and was maintained at 1 month of follow-up in 96% and 91% (P=.55), respectively. Cefazolin H3 histone pseudogene 44 Homo sapiens